Concepedia

Jeanette Harris

JH

Statistics

Publications

13

Citations

650

H-Index

13

Active since

2002

Affiliations

Gilead Sciences (United States)(Current)

Gilead Sciences (Australia)

Yeshiva University

Cloud Pharmaceuticals (United States)

University of the Witwatersrand

Jeanette Harris is an author at Gilead Sciences (United States) specializing in antiviral therapy, pharmacology, and antiretroviral therapy.

Publications per year

2002–2012

13

Publications

13

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, R. L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 125 citations

, , +11

Pharmacokinetic and Pharmacodynamic Characteristics of Emtricitabine Support Its Once Daily Dosing for the Treatment of HIV Infection

Laurene H. Wang, John Begley, Robert L. St. Claire et al. · AIDS Research and Human Retroviruses · 2004 · 109 citations

, , +11

Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

Andrew Bae, Siu-Chi Chang Sun, Xiaoping Qi et al. · Antimicrobial Agents and Chemotherapy · 2010 · 76 citations

, , +17

Dioxolane Guanosine, the Active Form of the Prodrug Diaminopurine Dioxolane, Is a Potent Inhibitor of Drug-Resistant HIV-1 Isolates From Patients for Whom Standard Nucleoside Therapy Fails

Jennifer P. Mewshaw, Florence Myrick, Debby A. C. S. Wakefield et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2002 · 66 citations

, , +17

Prospective Randomized Trial of Emtricitabine versus Lamivudine Short‐Term Monotherapy in Human Immunodeficiency Virus–Infected Patients

Franck Rousseau, Charles Wakeford, Herve Momméja-Marin et al. · The Journal of Infectious Diseases · 2003 · 65 citations · Full text

, , +17

1–5 of 13